Guarding U.S. Medicare against Rising Drug Costs Model (GUARD) (CMS-5546-P)
Summary
The federal government is proposing a new program called GUARD that aims to help Medicare control the rising costs of prescription drugs. This regulation would give Medicare more power to negotiate drug prices and potentially save money for seniors and the overall healthcare system.
Key Points
- 1Medicare would have stronger tools to negotiate lower prices directly with pharmaceutical companies for expensive drugs
- 2The rule applies to Medicare Part D (prescription drug coverage) and could affect prices seniors pay at the pharmacy
- 3Drug manufacturers would need to participate in price negotiations or face financial penalties
- 4The program is still in proposal stage, and the public has until February 24, 2026 to submit comments before the rule is finalized
- 5The goal is to reduce healthcare spending on drugs while ensuring seniors maintain access to needed medications
Impact Assessment
If you are a Medicare beneficiary, this means the federal government would have greater ability to negotiate lower prescription drug prices on your behalf, potentially reducing your out-of-pocket costs for medications.
National
Significant
Key Dates
December 23, 2025
Regulatory Connections
This summary is for informational purposes only. It may not capture all nuances of the regulation. Always refer to the official text for authoritative information.
The Digest Network
AI Comment Drafter
Describe your concern and we'll help you draft a substantive comment.
AI-generated draft. Always review and edit before submitting. Replace all [bracketed placeholders] with your specific details. Your comment should reflect your genuine views and experience.